Our Addiction Professionals group on LinkedIn generates many thought-provoking and spirited discussions. One that caught my eye this week seeks opinions about the influx of physicians in addiction treatment. The discussion generated this comment from treatment program administrator Andrew Spanswick (whose KLEAN facility in California, by the way, will be featured in Addiction Professional’s July/August print issue):
“Addiction medicine has become the new cash cow for physicians due to buprenorphine.”
Spanswick followed up that statement with a prediction: “This will pass as general practitioners discover the difficulties in managing clients with addiction.”
Does this reflect what you’re seeing in the field? Share your opinions with a comment here.
